{{Rsnum
|rsid=9813712
|Gene=COL6A4P2
|Chromosome=3
|position=130252258
|Orientation=plus
|GMAF=0.2378
|Gene_s=COL6A4P2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;T)
| geno3=(T;T)
| CEU | 5.3 | 32.7 | 61.9
| HCB | 2.2 | 28.7 | 69.1
| JPT | 11.5 | 38.9 | 49.6
| YRI | 12.9 | 37.4 | 49.7
| ASW | 21.1 | 40.4 | 38.6
| CHB | 2.2 | 28.7 | 69.1
| CHD | 1.8 | 35.8 | 62.4
| GIH | 7.9 | 37.6 | 54.5
| LWK | 14.5 | 47.3 | 38.2
| MEX | 8.6 | 39.7 | 51.7
| MKK | 23.1 | 56.4 | 20.5
| TSI | 2.9 | 27.5 | 69.6
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=22952603
  |Trait=Response to amphetamines
  |Title=Genome-wide association study of d-amphetamine response in healthy volunteers identifies putative associations, including cadherin 13 (CDH13).
  |RiskAllele=
  |Pval=2E-6
  |OR=NR
  |ORtxt=NR
  |OA=1
}}

{{on chip | Affy GenomeWide 6}}